Premium
CeriBell Inc (CBLL)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Mr. Joseph Sean ManniChief Revenue Officer | -1,38k | 24,80k | Vente | 18,00 | 56,29k | -2,39% |
| 2026-05-22 | Mr. David FoehrSVP of Finance | -862,00 | 16,21k | Automatic Disposition | 18,80 | 37,75k | -2,23% |
| 2026-05-21 | Mr. David FoehrSVP of Finance | -987,00 | 17,77k | Vente | 18,00 | 37,75k | -2,55% |
| 2026-05-21 | Dr. Raymond WooCTO | -1,97k | 35,39k | Vente | 18,00 | 195,68k | -0,99% |
| 2026-05-21 | Mr. Scott BlumbergCFO | -1,39k | 24,97k | Vente | 18,00 | 93,93k | -1,46% |
| 2026-05-21 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -6,03k | 108,54k | Vente | 18,00 | 1,03M | -0,58% |
| 2026-05-05 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -14,00k | 281,68k | Automatic Disposition | 20,12 | 1,04M | -1,33% |
| 2026-05-05 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -25,00k | 16,35B | Derivative Exercise and Sale | 4,70 - 694,13k | 1,04M | - |
| 2026-04-06 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -25,00k | 342,50k | Derivative Exercise and Sale | 4,70 - 18,40 | 661,84k | - |
| 2026-04-06 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -14,00k | 257,60k | Automatic Disposition | 18,40 | 661,84k | -2,07% |
| 2026-04-01 | Dr. Raymond WooCTO | -11,11k | 157,64k | Derivative Exercise and Sale | 2,24 - 18,58 | 483,39k | - |
| 2026-03-25 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | 55,63k | 151,40k | Derivative Exercise and Retained Stock | 2,24 - 3,65 | 675,84k | 8,97% |
| 2026-03-03 | Mr. David FoehrSVP of Finance | -4,56k | 59,74k | Derivative Exercise and Sale | 4,70 - 17,80 | 17,55k | - |
| 2026-03-03 | Ms. Rebecca B. RobertsonIndependent Chairman of the Board | -827,00 | 14,72k | Automatic Disposition | 17,80 | 18,75k | -4,22% |
| 2026-03-03 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -25,00k | 318,76k | Derivative Exercise and Sale | 4,70 - 17,46 | 620,21k | - |
| 2026-03-03 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -14,00k | 244,30k | Automatic Disposition | 17,45 | 620,21k | -2,21% |
| 2026-03-02 | Dr. Raymond WooCTO | 3,03k | 14,22k | Derivative Exercise and Retained Stock | 4,70 | 483,39k | 0,63% |
| 2026-03-02 | Dr. Raymond WooCTO | -8,09k | 113,21k | Derivative Exercise and Sale | 2,24 - 18,26 | 483,39k | - |
| 2026-02-23 | Mr. David FoehrSVP of Finance | -569,00 | 11,26k | Vente | 19,79 | 17,55k | -3,14% |
| 2026-02-24 | Mr. David FoehrSVP of Finance | -781,00 | 15,60k | Automatic Disposition | 19,98 | 17,55k | -4,26% |
| 2026-02-23 | Dr. Raymond WooCTO | -705,00 | 13,95k | Vente | 19,79 | 483,39k | -0,15% |
| 2026-02-23 | Mr. Joseph Sean ManniChief Revenue Officer | -768,00 | 15,20k | Vente | 19,79 | 26,93k | -2,77% |
| 2026-02-23 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -2,08k | 41,24k | Vente | 19,79 | 634,21k | -0,33% |
| 2026-02-23 | Mr. Scott BlumbergCFO | -808,00 | 15,99k | Vente | 19,79 | 87,64k | -0,91% |
| 2026-02-19 | Dr. Josef ParviziCo-Founder, Chief Medical Advisor & Director | -16,71k | 338,79k | Automatic Disposition | 20,27 | 2,00M | -0,83% |
| 2026-02-17 | Dr. Josef ParviziCo-Founder, Chief Medical Advisor & Director | -8,29k | 165,72k | Automatic Disposition | 20,00 | 739,37k | -1,11% |
| 2026-02-04 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -25,00k | 386,50k | Derivative Exercise and Sale | 4,70 - 20,16 | 636,30k | - |
| 2026-02-04 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -14,00k | 282,24k | Automatic Disposition | 20,16 | 636,30k | -2,15% |
| 2026-02-03 | Mr. David FoehrSVP of Finance | -5,56k | 85,01k | Derivative Exercise and Sale | 4,70 - 20,00 | 18,90k | - |
| 2026-02-02 | Dr. Raymond WooCTO | -11,11k | 179,77k | Derivative Exercise and Sale | 2,24 - 20,57 | 484,10k | - |
| 2026-01-15 | Dr. Josef ParviziCo-Founder, Chief Medical Advisor & Director | -25,00k | 573,50k | Automatic Disposition | 22,94 | 747,65k | -3,24% |
| 2025-11-20 | Mr. Joseph Sean ManniChief Revenue Officer | -660,00 | 9,00k | Sale to Issuer | 13,64 | 27,40k | -2,35% |
| 2026-01-05 | Mr. David FoehrSVP of Finance | -5,56k | 99,45k | Derivative Exercise and Sale | 4,70 - 22,60 | 18,90k | - |
| 2025-11-20 | Mr. David FoehrSVP of Finance | -484,00 | 6,60k | Sale to Issuer | 13,64 | 18,90k | -2,50% |
| 2026-01-05 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -25,00k | 411,81k | Derivative Exercise and Sale | 4,70 - 21,21 | 650,30k | - |
| 2026-01-05 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -54,00k | 1,15M | Automatic Disposition | 21,31 | 650,30k | -7,67% |
| 2025-11-20 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -2,89k | 39,38k | Sale to Issuer | 13,64 | 650,30k | -0,44% |
| 2026-01-02 | Dr. Raymond WooCTO | -11,11k | 186,78k | Derivative Exercise and Sale | 2,24 - 21,29 | 483,80k | - |
| 2025-11-20 | Dr. Raymond WooCTO | -687,00 | 9,37k | Sale to Issuer | 13,64 | 483,80k | -0,14% |
| 2025-06-17 | Ms. Rebecca B. RobertsonIndependent Chairman of the Board | -7,45k | 131,26k | Automatic Disposition | 17,63 | 21,23k | -25,96% |
| 2026-01-02 | Ms. Rebecca B. RobertsonIndependent Chairman of the Board | -2,50k | 49,13k | Derivative Exercise and Sale | 2,24 - 21,89 | 19,58k | - |
| 2025-12-22 | Mr. Scott BlumbergCFO | -36,00k | 603,90k | Derivative Exercise and Sale | 3,65 - 21,00 | 88,15k | - |
| 2025-11-20 | Mr. Scott BlumbergCFO | -687,00 | 9,37k | Sale to Issuer | 13,64 | 88,15k | -0,77% |
| 2025-12-15 | Dr. Josef ParviziCo-Founder, Chief Medical Advisor & Director | -25,00k | 537,25k | Automatic Disposition | 21,49 | 763,82k | -3,17% |
| 2025-12-09 | Mr. William W. BurkeIndependent Director | -32,73k | 590,59k | Derivative Exercise and Sale | 2,26 - 22,02 | 8,56k | - |
| 2025-12-08 | Dr. Josef ParviziCo-Founder, Chief Medical Advisor & Director | -25,00k | 506,50k | Automatic Disposition | 20,26 | 788,82k | -3,07% |
| 2025-12-08 | Ms. Rebecca B. RobertsonIndependent Chairman of the Board | -5,00k | 88,80k | Derivative Exercise and Sale | 2,24 - 20,00 | 8,39k | - |
| 2025-12-04 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -25,00k | 414,50k | Derivative Exercise and Sale | 2,24 - 18,82 | 707,19k | - |
| 2025-12-03 | Mr. David FoehrSVP of Finance | -4,40k | 53,36k | Derivative Exercise and Sale | 4,70 - 16,83 | 19,38k | - |
| 2025-12-03 | Mr. David FoehrSVP of Finance | -866,00 | 14,57k | Automatic Disposition | 16,83 | 19,38k | -4,28% |
| 2025-12-02 | Ms. Rebecca B. RobertsonIndependent Chairman of the Board | -827,00 | 13,79k | Automatic Disposition | 16,67 | 8,39k | -8,97% |
| 2025-12-01 | Dr. Raymond WooCTO | -11,11k | 87,85k | Derivative Exercise and Sale | 2,24 - 12,28 | 484,18k | - |
| 2025-12-01 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -25,00k | 323,50k | Derivative Exercise and Sale | 3,65 - 16,59 | 707,19k | - |
| 2025-11-21 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -50,00k | 609,25k | Derivative Exercise and Sale | 2,24 - 15,13 | 707,19k | - |
| 2025-11-11 | Dr. Raymond WooCTO | -11,11k | 87,85k | Derivative Exercise and Sale | 2,24 - 12,28 | 484,18k | - |
| 2025-10-03 | Dr. Raymond WooCTO | -11,11k | 90,74k | Derivative Exercise and Sale | 2,24 - 12,54 | 484,18k | - |
| 2025-04-22 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | 15,93k | 35,68k | Derivative Exercise and Retained Stock | 2,24 | 677,13k | 2,41% |
| 2025-04-17 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | 9,07k | 20,32k | Derivative Exercise and Retained Stock | 2,24 | 670,27k | 1,37% |
| 2025-09-04 | Dr. Raymond WooCTO | -11,11k | 85,96k | Derivative Exercise and Sale | 2,24 - 12,11 | 484,18k | - |
| 2025-09-03 | Ms. Rebecca B. RobertsonIndependent Chairman of the Board | -827,00 | 9,39k | Automatic Disposition | 11,36 | 9,22k | -8,24% |
| 2025-09-02 | Dr. Raymond WooCTO | 20,00k | 44,80k | Derivative Exercise and Retained Stock | 2,24 | 484,18k | 4,31% |
| 2025-08-27 | Mr. David FoehrSVP of Finance | -866,00 | 10,14k | Vente | 11,71 | 20,25k | -4,10% |
| 2025-08-25 | Mr. David FoehrSVP of Finance | -484,00 | 5,60k | Sale to Issuer | 11,58 | 21,12k | -2,24% |
| 2025-08-25 | Mr. Joseph Sean ManniChief Revenue Officer | -660,00 | 7,64k | Sale to Issuer | 11,58 | 27,76k | -2,32% |
| 2025-08-25 | Dr. Raymond WooCTO | -687,00 | 7,96k | Sale to Issuer | 11,58 | 464,18k | -0,15% |
| 2025-08-25 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -2,89k | 33,43k | Sale to Issuer | 11,58 | 682,19k | -0,42% |
| 2025-08-25 | Mr. Scott BlumbergCFO | -687,00 | 7,96k | Sale to Issuer | 11,58 | 88,68k | -0,77% |
| 2025-08-19 | Mr. Joseph M. TaylorIndependent Director | -7,03k | 82,70k | Vente | 11,76 | 59,24k | -10,61% |
| 2025-07-07 | Dr. Xingjuan ChaoCo-Founder, President, CEO & Director | -25,00k | 386,50k | Derivative Exercise and Sale | 2,24 - 17,70 | 685,07k | - |
| 2025-06-16 | Ms. Rebecca B. RobertsonIndependent Chairman of the Board | -20,00k | 270,57k | Derivative Exercise and Sale | 2,24 - 17,14 | 28,68k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
